Aaron Royston
SelectiveNamed in filings at Venbio Global StrategicOn the current fund
- Board seats filed
- 11
- Named on a board
all filings on record
Named in filings at Venbio Global StrategicOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Caldera Therapeutics | Biotech & pharma | January 2026 | Atlas Venture |
| Arpeggio Biosciences | Biotech & pharma | November 2025 | Westlake Biopartners |
| Marea Therapeutics | Biotech & pharma | June 2024 | Sofinnova Venture Partners, Third Rock Ventures |
| Neurogastrx | Biotech & pharma | June 2021 | Westlake Biopartners |
| Ventyx Biosciences | Not yet classified | February 2021 | None on file |
| RayzeBio | Biotech & pharma | August 2020 | Sofinnova Venture Partners, Versant Venture Capital |
| Swift Health Systems | Medical devices | June 2019 | 270 Healthcare Growth |
| Akero Therapeutics | Biotech & pharma | December 2018 | Atlas Venture |
| Harmony Biosciences II | Biotech & pharma | September 2017 | Valor Siren Ventures, Vivo Innovation |
| Menlo Therapeutics | Biotech & pharma | July 2017 | Vivo Innovation |
| IMPEL NEUROPHARMA | Biotech & pharma | November 2016 | Westlake Biopartners |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Aaron Royston on the board, based on 10 filed seats with a verified or cited source.
1 more filed seat not yet classified, left out of the shares above.